Next Life Sciences
PrivateLast Round
Series A
Mar 24, 2025
Total Funding Raised
$17.9M
Company Overview
Next Life Sciences operates in Healthcare & Life Sciences and is based in San Luis Obispo, California. Its latest recorded funding round was a Grant round in February 2024.
Next Life Sciences is a biotechnology company developing Plan A, a non-hormonal, long-acting, and reversible male contraceptive medical device.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Next Life Sciences Comparables
Compare Next Life Sciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Contraline | 91% | |
| YourChoice Therapeutics | 84% | |
| VasDeBlock medical ApS | 83% |
For institutional investors. Book with your work email.
Next Life Sciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 24, 2025 | ||||
| Grant | Feb 28, 2024 | ||||
| Seed | Jan 18, 2024 | ||||
| Seed | Jun 5, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Next Life Sciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Male Contraceptive Initiative | Grant |
| Joy Fund | Seed |
| TheFamily | Seed |
| The Pay It Forward Company | Seed |
| Particular Ventures | Seed |
| Transform VC | Seed |
| Unpopular Ventures | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 27, 2025
FDA regulatory expert Peter Barton Hutt joins advisory board.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingSep 25, 2026
NEXT Life Sciences, Inc. is working on Plan A, a reversible implant intended to provide longer-term contraception by keeping sperm at bay for years, as of Sep '26.
For institutional investors. Book with your work email.
Next Life Sciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Next Life Sciences's valuation, stock price, and market status.
Is Next Life Sciences a public or private company?
Next Life Sciences is a private company.
What is the current stock price of Next Life Sciences?
Next Life Sciences is a private company, so its shares have no public market price. Caplight tracks Next Life Sciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Next Life Sciences worth (valuation)?
Valuation information for Next Life Sciences is not publicly available.
Can I buy Next Life Sciences stock?
Next Life Sciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Next Life Sciences's last funding round?
Next Life Sciences's most recent funding round was Series A on March 24, 2025.
Who are the main investors in Next Life Sciences?
Key investors in Next Life Sciences include TheFamily.
Will Next Life Sciences IPO soon?
No public IPO plans have been announced for Next Life Sciences.
How can I track Next Life Sciences secondary market activity?
Caplight tracks bids, offers, and trades in Next Life Sciences's shares on secondary markets.